Literature DB >> 21084059

Duchenne muscular dystrophy--what causes the increased membrane permeability in skeletal muscle?

David G Allen1, Nicholas P Whitehead.   

Abstract

Duchenne muscular dystrophy is a severe muscle wasting disease caused by a mutation in the gene for dystrophin--a cytoskeletal protein connecting the contractile machinery to a group of proteins in the cell membrane. At the end stage of the disease there is profound muscle weakness and atrophy. However, the early stage of the disease is characterised by increased membrane permeability which allows soluble enzymes such as creatine kinase to leak out of the cell and ions such as calcium to enter the cell. The most widely accepted theory to explain the increased membrane permeability is that the absence of dystrophin makes the membrane more fragile so that the stress of contraction causes membrane tears which provide the increase in membrane permeability. However other possibilities are that increases in intracellular calcium caused by altered regulation of channels activate enzymes, such as phospholipase A(2), which cause increased membrane permeability. Increases in reactive oxygen species (ROS) are also present in the early stages of the disease and may contribute both to membrane damage by peroxidation and to the channel opening. Understanding the earliest phases of the pathology are critical to therapies directed at minimizing the muscle damage. Crown
Copyright © 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084059     DOI: 10.1016/j.biocel.2010.11.005

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  52 in total

1.  Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy.

Authors:  Noah Weisleder; Norio Takizawa; Peihui Lin; Xianhua Wang; Chunmei Cao; Yan Zhang; Tao Tan; Christopher Ferrante; Hua Zhu; Pin-Jung Chen; Rosalie Yan; Matthew Sterling; Xiaoli Zhao; Moonsun Hwang; Miyuki Takeshima; Chuanxi Cai; Heping Cheng; Hiroshi Takeshima; Rui-Ping Xiao; Jianjie Ma
Journal:  Sci Transl Med       Date:  2012-06-20       Impact factor: 17.956

Review 2.  Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials.

Authors:  Yuko Shimizu-Motohashi; Shouta Miyatake; Hirofumi Komaki; Shin'ichi Takeda; Yoshitsugu Aoki
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

3.  Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy.

Authors:  Nandita Niranjan; Satvik Mareedu; Yimin Tian; Kasun Kodippili; Nadezhda Fefelova; Antanina Voit; Lai-Hua Xie; Dongsheng Duan; Gopal J Babu
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

4.  A 3-base pair deletion, c.9711_9713del, in DMD results in intellectual disability without muscular dystrophy.

Authors:  Arjan P M de Brouwer; Sander B Nabuurs; Ingrid E C Verhaart; Astrid R Oudakker; Roel Hordijk; Helger G Yntema; Jannet M Hordijk-Hos; Krysta Voesenek; Bert B A de Vries; Ton van Essen; Wei Chen; Hao Hu; Jamel Chelly; Johan T den Dunnen; Vera M Kalscheuer; Annemieke M Aartsma-Rus; Ben C J Hamel; Hans van Bokhoven; Tjitske Kleefstra
Journal:  Eur J Hum Genet       Date:  2013-07-31       Impact factor: 4.246

5.  Time-Dependent Influence of Cell Membrane Permeability on MR Diffusion Measurements.

Authors:  Hua Li; Xiaoyu Jiang; Jingping Xie; J Oliver McIntyre; John C Gore; Junzhong Xu
Journal:  Magn Reson Med       Date:  2015-06-11       Impact factor: 4.668

6.  Comparative study of calcium and calcium-related enzymes with differentiation markers in different ages and muscle types in mdx mice.

Authors:  Rhayanna B Gaglianone; Flavia Fonseca Bloise; Tania Maria Ortiga-Carvalho; Thereza Quirico-Santos; Manoel Luis Costa; Claudia Mermelstein
Journal:  Histol Histopathol       Date:  2019-07-05       Impact factor: 2.303

7.  Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy.

Authors:  Jérome Chal; Masayuki Oginuma; Ziad Al Tanoury; Bénédicte Gobert; Olga Sumara; Aurore Hick; Fanny Bousson; Yasmine Zidouni; Caroline Mursch; Philippe Moncuquet; Olivier Tassy; Stéphane Vincent; Ayako Miyanari; Agata Bera; Jean-Marie Garnier; Getzabel Guevara; Marie Hestin; Leif Kennedy; Shinichiro Hayashi; Bernadette Drayton; Thomas Cherrier; Barbara Gayraud-Morel; Emanuela Gussoni; Frédéric Relaix; Shahragim Tajbakhsh; Olivier Pourquié
Journal:  Nat Biotechnol       Date:  2015-08-03       Impact factor: 54.908

8.  DMD carrier model with mosaic dystrophin expression in the heart reveals complex vulnerability to myocardial injury.

Authors:  Tatyana A Meyers; Jackie A Heitzman; DeWayne Townsend
Journal:  Hum Mol Genet       Date:  2020-04-15       Impact factor: 6.150

9.  The Emerging Roles of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 in Skeletal Muscle Redox Signaling and Metabolism.

Authors:  Carlos Henríquez-Olguín; Susanna Boronat; Claudio Cabello-Verrugio; Enrique Jaimovich; Elena Hidalgo; Thomas E Jensen
Journal:  Antioxid Redox Signal       Date:  2019-11-01       Impact factor: 8.401

10.  Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts.

Authors:  Tatyana A Meyers; Jackie A Heitzman; Aimee M Krebsbach; Lauren M Aufdembrink; Robert Hughes; Alessandro Bartolomucci; DeWayne Townsend
Journal:  J Mol Cell Cardiol       Date:  2019-01-19       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.